GVK Biosciences inks pact with US-based Onconova Therapeutics Inc

09 Jan 2013 Evaluate

GVK Biosciences, part of the diversified GVK Group, has inked pact with US-based Onconova Therapeutics Inc, to develop new drugs to treat cancer. Onconova is a late-stage biopharmaceutical company focused on the development of new therapies for the treatment of cancer and radiation injury.

As part of the agreement, Onconova will provide two early stage oncology discovery targets, while Hyderabad-based GVK will use its multi-disciplinary discovery platform to facilitate moving these targets from early discovery to clinical development stage. Further, GVK Biosciences will gain an increasing share of the programmes as the company advances up to a 50:50 split of revenue based on achievement of milestones/funding brought into the joint partnership. However, Onconova retains the rights to buy back the programmes.

GVK Power & Infrastructure (GVKPIL) is the flagship company of Hyderabad-based GVK Group that encompasses several primary business sectors such Energy, coal, oil and gas, transportation, hospitality and Life sciences.

GVK Power & Infra Share Price

2.96 0.00 (0.00%)
22-Jan-2026 10:16 View Price Chart
Peers
Company Name CMP
NTPC 341.20
Tata Power 352.10
Adani Power 139.70
Power Grid Corp 257.60
Torrent Power 1310.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×